(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise...
Stats | |
---|---|
今日成交量 | 646 116 |
平均成交量 | 929 131 |
市值 | 1.23B |
EPS | £0 ( 2023-09-06 ) |
下一个收益日期 | ( £0 ) 2024-05-23 |
Last Dividend | £21.10 ( 2023-06-15 ) |
Next Dividend | £0 ( N/A ) |
P/E | 40.89 |
ATR14 | £9.82 (0.51%) |
音量 相关性
EMIS Group PLC 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
EMIS Group PLC 相关性 - 货币/商品
EMIS Group PLC 财务报表
Annual | 2022 |
营收: | £175.37M |
毛利润: | £162.47M (92.64 %) |
EPS: | £0.530 |
FY | 2022 |
营收: | £175.37M |
毛利润: | £162.47M (92.64 %) |
EPS: | £0.530 |
FY | 2021 |
营收: | £168.23M |
毛利润: | £151.97M (90.34 %) |
EPS: | £0.462 |
FY | 2020 |
营收: | £159.45M |
毛利润: | £139.12M (87.25 %) |
EPS: | £0.481 |
Financial Reports:
No articles found.
EMIS Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£17.60 (N/A) |
£0 (N/A) |
£21.10 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £5.60 | 2010-09-22 |
Last Dividend | £21.10 | 2023-06-15 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 27 | -- |
Total Paid Out | £308.10 | -- |
Avg. Dividend % Per Year | 1.42% | -- |
Score | 4.57 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.22 | |
Div. Directional Score | 9.09 | -- |
Year | Amount | Yield |
---|---|---|
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £27.10 | 3.18% |
2019 | £29.80 | 3.24% |
2020 | £31.60 | 2.82% |
2021 | £33.60 | 3.03% |
2022 | £35.20 | 2.65% |
2023 | £21.10 | 1.13% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RTO.L | Dividend Knight | 2023-08-03 | Annually | 32 | 0.88% | |
HILS.L | Dividend King | 2023-11-30 | Semi-Annually | 32 | 1.26% | |
AXI.L | Dividend Knight | 2023-08-03 | Quarterly | 9 | 4.00% | |
VP.L | Dividend Knight | 2023-06-22 | Annually | 33 | 2.60% | |
MSLH.L | Dividend Knight | 2023-10-19 | Annually | 33 | 1.56% | |
DNLM.L | Dividend King | 2023-10-26 | Semi-Annually | 18 | 3.31% | |
SKG.L | Dividend King | 2023-09-28 | Semi-Annually | 17 | 2.40% | |
IMB.L | Dividend King | 2023-08-17 | Quarterly | 28 | 4.66% | |
BOWL.L | Dividend Knight | 2023-06-08 | Annually | 8 | 1.03% | |
ORIT.L | Dividend Knight | 2023-08-17 | Quarterly | 5 | 2.77% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.189 | 1.500 | 6.22 | 9.33 | [0 - 0.5] |
returnOnAssetsTTM | 0.148 | 1.200 | 5.08 | 6.10 | [0 - 0.3] |
returnOnEquityTTM | 0.245 | 1.500 | 8.39 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.669 | -1.000 | 3.31 | -3.31 | [0 - 1] |
currentRatioTTM | 1.210 | 0.800 | 8.95 | 7.16 | [1 - 3] |
quickRatioTTM | 0.649 | 0.800 | -0.887 | -0.709 | [0.8 - 2.5] |
cashRatioTTM | 0.649 | 1.500 | 7.50 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0194 | -1.500 | 9.68 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 52.25 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.722 | 2.00 | 9.76 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.611 | 2.00 | 9.69 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0306 | -1.500 | 9.88 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.926 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.158 | 1.000 | 8.84 | 8.84 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 10.59 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.780 | 0.800 | 8.13 | 6.51 | [0.5 - 2] |
Total Score | 12.95 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.07 | 1.000 | 6.36 | 0 | [1 - 100] |
returnOnEquityTTM | 0.245 | 2.50 | 8.97 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.611 | 2.00 | 9.80 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.21 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.722 | 2.00 | 9.76 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.669 | 1.500 | 3.31 | -3.31 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.263 | 1.000 | 5.91 | 0 | [0.1 - 0.5] |
Total Score | 5.22 |
EMIS Group PLC
EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web, which enables patients to order repeat medication online and track progress from order to home delivery; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。